TScan Therapeutics Inc.

12/02/2024 | Press release | Distributed by Public on 12/02/2024 06:00

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Heme Development Strategy